Related Experiment Video
Updated: Aug 8, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Cushing's syndrome from Klack's solution
1Endocrine and Diabetes Management Center Inc, 7231 Forest Ave, Suite 103, Richmond, VA 23226, USA.
Summary
A 36-year-old man developed Cushing's syndrome due to Klack's solution, a remedy containing a potent corticosteroid. This case highlights the risks of unmonitored corticosteroid use in topical treatments.
Area of Science:
- Endocrinology
- Dermatology
- Pharmacology
Background:
- Cushing's syndrome is a hormonal disorder caused by prolonged exposure to high cortisol levels.
- Topical corticosteroids are widely used for various skin conditions, but systemic absorption can lead to adverse effects.
Observation:
- A case of Cushing's syndrome is reported in a 36-year-old male patient using Klack's solution for oral lichen planus.
- Klack's solution is a multi-component topical remedy, with one formulation found to contain a high concentration of corticosteroid.
Findings:
- The patient's Cushing's syndrome was directly attributed to the use of Klack's solution.
- Evaluation of corticosteroid-induced Cushing's syndrome requires careful assessment of all potential sources, dosages, and patient compliance.
Implications:
- This case underscores the importance of recognizing the potency and potential systemic harm of topical corticosteroids.
- Healthcare providers must be vigilant about the composition and strength of compounded medications like Klack's solution to prevent iatrogenic corticosteroid excess.
Related Concept Videos
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...